Connect with us

Hi, what are you looking for?

Tuesday, Dec 23, 2025

Mugglehead Investment Magazine

Alternative investment news based in Vancouver, B.C.

Mugglehead Investment Magazine

All posts tagged "Delix Therapeutics"

Enveric Biosciences skyrockets on patent allowance for psychedelic-inspired molecules

Enveric Biosciences skyrockets on patent allowance for psychedelic-inspired molecules

Psychedelics

Enveric Biosciences skyrockets on patent allowance for psychedelic-inspired molecules

Lead drug candidate EB-301 is structurally similar to DMT

Rowan DunneDecember 11, 2025

Scientists coin the term 'PiPi drugs': a new frontier in psychedelic medicine

Scientists coin the term 'PiPi drugs': a new frontier in psychedelic medicine

Psychedelics

Scientists coin the term ‘PiPi drugs’: a new frontier in psychedelic medicine

Non-psychoactive therapeutics derived from psychedelic compounds have promising anti-inflammatory properties

Rowan DunneSeptember 5, 2025

Delix Therapeutics starts clinical trial examining novel psychoplastogen drug

Delix Therapeutics starts clinical trial examining novel psychoplastogen drug

News

Delix Therapeutics to start clinical trial on novel psychoplastogen drug

DLX-001 is a non-hallucinogenic compound intended to treat various mental health conditions

Rowan DunneMay 9, 2023

More Posts